Karsinoma Tiroid
Pembimbing:
dr. Dian Kurnia, Sp. B (K) Onk
INSIDENSI URUTAN 9
NATIONAL CANCER DATA BASE (NCDB), insidensi kanker tiroid pria sekitar 2,5
per 100.000 populasi
Wanita sekitar 6,7 per 100.000 populasi
• Non operatif
o kemoterapi, radioterapi, serta terapi hormon
Prognosis
• Prognosis keseluruhan kanker tiroid ditentukan oleh tipe
histopatologi, stadium klinik patologi, lamanya penyakit
terdiagnosa, kecukupan pengobatan, serta usia penderita.
Prognosis
• Dapat diketahui faktor prognosa pada karsinoma tiroid berdiferensiasi
baik bergantung pada :
• Umur : Semakin tua prognosa semakin buruk
• Eksistensi tumor ekstra tiroid : adanya eksistensi ekstra tiroid akan
menurunkan survival rate 20 tahun dari 91 % menjadi 45 %
• Adanya lesi metastase : adanya lesi metastasis pada penelitian Shah et
all melaporkan penurunan survival rate 20 tahun hingga 46 %
dibandingkan 90 % pada tanpa metastase
• Diameter tumor : Tumor ukuran > 4 cm prognosis 20 tahunn survival
rate 70 % dan 95 % untuk yang < 4 cm
• Histologi dan grading : Jenis papiliferum 20 years survival rate 93 %,
jenis folikuler 20 years survival rate 83 %
DAFTAR PUSTAKA
• Easterling TR, Otto C. Heart disease. In: Gabbe, editor. Obstetrics-
normal and problem pregnancies. 4 th ed. London: Churchill
Livingstone Inc; 2002. p. 1005-30.
• Childrens’s Hospital of the King’s Daughter. Multiple Pregnancy.
Available from: www.Chkd.org/High_Risk_Pregnancy/multiple.asp
[diakses 1 November 2018].
• Gei A, Hankins G. Medical complications of pregnancy cardiac
disease and pregnancy. Obstet and gynecol clin 2001;28 (3):1-42.
• Brauwald E. Valvular Heart Disease. 16 ed. Harrison’s Principles of
Internal Medicine. New York: Mc Graw-Hill, 2005
Daftar Pustaka
• Davies L, Ouellette M, Hunter M, dan Welch HG.The increasing incidence of small thyroid
cancers: where are the cases coming from?. Laryngoscope. 2010; 120: 2446-245.
• American Cancer Society. Cancer facts & figures. Atlanta: American Cancer Society; 2015
• Sosa JA, Hanna JW, Robinson KA, dan Lanman RB. Increases in thyroid nodule fine-needle
aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery. 2013;
154: 1420-1426
• Maenhut C, et al. Ontogeny, Anatomy, Metabolism and Physiology of the Thyroid. South
Dartmouth:MDText.com, Inc; 2015.
• Aaron DC, Findling JW, dan Tyrrel JB. Hypothalamus & pituitary gland. In: Gardner DG and
Shoback D (eds.) Greenspan’s basic & clinical endocrinology. 8th epp. New York: The
McGraw-Hill Companies;2007
• Khatawkar AV dan Awati SM. Thyroid gland: Historical aspects, Embryology, Anatomy and
Physiology. IAIM. 2015; 2(9):165-171.
• Shah JP. Thyroid Carcinoma: Epidemiology, Histology, and Diagnosis. Clin Adv Hematol
Oncol. 2015; 13(4 Suppl 4): 3–6.
• Didid T, dan Rukmini M. Cancer in Indonesia, Present and Future. Jpn J Clin Oncol.
2002;32(Supplement 1):17–21
• Robert U dan Yawei Z. The Epidemic of Thyroid Cancer in the United States: The Role of
Endocrinologists and Ultrasounds. Thyroid. 2014 Mar 1; 24(3): 472–479.
Daftar Pustaka
• Bilimoria KY, Stewart AK, Winchester DP, dan Ko, CY. The National Cancer Data Base: A Powerful Initiative to
Improve Cancer Care in the United States. Ann Surg Oncol. 2008; 15(3): 683–690.
• Yihao L, Lei S, dan Haipeng X. Review of Factors Related to the Thyroid Cancer Epidemic. Int J Endocrinol.
2017;1(1):1-9
• Liebner DA, dan Shah MH. Thyroid Cancer: Pathogenesis and Targeted Therapy. Ther Adv Endocrinol Metab. 2011
Oct; 2(5): 173–195.
• Massimo S, dan Francesca C. Central Role of RET in Thyroid Cancer. Cold Spring Harb Perspect Biol. 2013 Dec;
5(12):1-17
• Mingzhao X. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013 Mar; 13(3): 184–199.
• Daniela G. Current Knowledge in Thyroid Cancer—From Bench to Bedside. Int J Mol Sci. 2017 Jul; 18(7): 1529.
• Xu B, dan Ghossein R. Evolution of the histologic classification of thyroid neoplasms and its impact on clinical
management. EJSO. 2018;44(3):338–347
• Michael TR, Bryan H, dan Perrier ND. Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging
System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?. Thyroid.
2017;27(6):1-6
• Nguyen, QT. Diagnosis and Treatment of Patients with Thyroid Cancer. Am Health Drug Benefits. 2015 Feb; 8(1): 30–
40.
• Haugen B, Tuttle M, Wartofsky L. Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism.
2006;91(12):1-20.
• Somasundar PS, et al. Papillary Thyroid Carcinoma Differential Diagnoses. Medscape. 2018; 1(1):1-9.
• Aviram M dan Shaha AR. Lymph Node Dissection for Differentiated Thyroid Cancer. Mol Imaging Radionucl Ther.
2017 Feb; 26(1): 10–15.
• Sawka AM, et al. Managing Newly Diagnosed Thyroid Cancer. CMAJ. 2014 Mar 4;186(4): 269–275.
• Gonzalez RG, et al. Papillary Thyroid Carcinoma: Differential Diagnosis and Prognostic Values of Its Different Variants:
Review of the Literature. ISRN Oncol. 2011; 1(1):1-9